Who is the CEO of TRVI? | Glauxie AI

Q: Who is the CEO of TRVI?

Trevi Therapeutics, Inc. (TRVI) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Jennifer L. Good. Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is... Employees: 34.

Q: What does TRVI company do?

Learn what TRVI does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling TRVI?

Track recent insider buys and sells for TRVI with transaction details, amounts, and trends.

Q: What sector is TRVI in?

Find TRVI sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of TRVI?

🦉

Trevi Therapeutics, Inc. (TRVI)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOJennifer L. Good

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III...

Key Executives

Name	Title
Christopher Galletta	Controller & Chief Accounting Officer
David C. Hastings	Chief Financial Officer & Principal Financial Officer
Farrell Simon	Chief Commercial Officer
James V. Cassella	Chief Development Officer
Jennifer L. Good	Co-Founder, Chief Executive Officer, President & Director
Katherine Takaki	Senior Vice President of Global Regulatory Affairs

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

TRVI Profile Financials

What does TRVI company do? Are insiders buying or selling TRVI? What sector is TRVI in?